Kathy Petoumenos

Kathy Petoumenos publications per year

Kathy Petoumenos publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Kathy Petoumenos sits on this spectrum.

Kathy Petoumenos D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Kathy Petoumenos sits on this spectrum.

Best Publications

• Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis

  Dorothy A Machalek;Mary Poynten;Fengyi Jin;Christopher K Fairley

  1124
  Citations

• Lipid Profiles in HIV-Infected Patients Receiving Combination Antiretroviral Therapy: Are Different Antiretroviral Drugs Associated with Different Lipid Profiles?

  E Fontas;F van Leth;C A Sabin;N Friis-Møller

  433
  Citations

• Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.

  Jason Grebely;Kathy Petoumenos;Margaret Hellard;Margaret Hellard;Gail V. Matthews;Gail V. Matthews

  249
  Citations

• Rates of cardiovascular disease following smoking cessation in patients with HIV infection: Results from the D:A:D study

  K Petoumenos;S Worm;P Reiss;S de Wit

  228
  Citations

• HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy

  D Lincoln;K Petoumenos;GJ Dore

  199
  Citations

• Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas.

  Janet Knox;Sepehr N Tabrizi;Penny Miller;Kathy Petoumenos

  182
  Citations

• Effective treatment of injecting drug users with recently acquired Hepatitis C virus infection

  Gregory J. Dore;Gregory J. Dore;Margaret Hellard;Margaret Hellard;Gail V. Matthews;Gail V. Matthews;Jason Grebely

  178
  Citations

• Predictors of Hypertension and Changes of Blood Pressure in HIV-Infected Patients:

  Rodolphe Thiebaut;Wafaa El-Sadr;Nina Friis-Møller;Martin M. Rickenbach

  172
  Citations

• Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection.

  Jason Grebely;Son Truong Pham;Gail V. Matthews;Kathy Petoumenos

  134
  Citations

• Does Choice of Combination Antiretroviral Therapy (cART) Alter Changes in Cerebral Function Testing after 48 Weeks in Treatment-Naive, HIV-1–Infected Individuals Commencing cART? A Randomized, Controlled Study

  Alan Winston;Chris Duncombe;Patrick C. K. Li;John M. Gill

  129
  Citations

• Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.

  Hamish McManus;Catherine C. O'Connor;Catherine C. O'Connor;Catherine C. O'Connor;Mark Boyd;Jennifer Broom

  100
  Citations

• Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.

  Christopher J. Miller;Jason V. Baker;Jason V. Baker;Alison M. Bormann;Kristine M. Erlandson

  98
  Citations

• HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults.

  Nila J Dharan;Paul Yeh;Mark Bloch;Miriam M Yeung;Miriam M Yeung

  96
  Citations

• Plasma interferon‐gamma‐inducible protein‐10 (IP‐10) levels during acute hepatitis C virus infection

  Jason Grebely;Jordan J. Feld;Tanya Applegate;Gail V. Matthews;Gail V. Matthews

  94
  Citations

• Rates of combination antiretroviral treatment change in Australia, 1997-2000.

  K. Petoumenos;D. Austin;D. Baker;M. Block

  90
  Citations

• Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons

  Margalida Rotger;Tracy R. Glass;Thomas Junier;Thomas Junier;Jens Lundgren

  88
  Citations

• HCV reinfection incidence among individuals treated for recent infection.

  Marianne Martinello;Jason Grebely;Kathy Petoumenos;Edward Gane

  87
  Citations

• Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

  Kathy Petoumenos;Signe W. Worm;Eric Fontas;Rainer Weber

  86
  Citations

• Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users

  Jason Grebely;Gail V. Matthews;Gail V. Matthews;Margaret Hellard;Margaret Hellard;David Shaw

  80
  Citations

• Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment - naive, HIV-infected subjects: week 48 data from the Altair study

  Rebekah L. Puls;Preeyaporn Srasuebkul;Kathy Petoumenos;Christoph Boesecke

  79
  Citations